Prof Dr. Apostolia Maria Tsimberidou | Medical Oncology | Best Researcher Award

Publications

Convergence of evolving artificial intelligence and machine learning techniques in precision oncology

  • Author: E. Fountzilas, T.E. Pearce, M.A. Baysal, A. Chakraborty, A.M. Tsimberidou
    Journal: npj Digital Medicine
    Year: 2025

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers

  • Author: J. Ahmed, F. Janku, D.D. Karp, F. Meric-Bernstam, A. Naing
    Journal: Cancer
    Year: 2025

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study

  • Author: K.Z. Thein, D.D. Karp, A.M. Tsimberidou, F. Meric-Bernstam, A. Naing
    Journal: Investigational New Drugs
    Year: 2025

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

  • Author: B.A. Wilky, G.K. Schwartz, M.S. Gordon, R.L. Jones, A.M. Tsimberidou
    Journal: Journal of Clinical Oncology
    Year: 2025

A multivariate Polya tree model for meta-analysis with event-time distributions

  • Author: G. Poli, E. Fountzilas, A.M. Tsimberidou, P.J. Müller
    Journal: Biometrics
    Year: 2024

Mrs. Golnaz Atri Roozbahani | Prostate Cancer Research | Best Researcher Award

Publications

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Cancers
  • Year: 2025

The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and-agonist to stimulate growth of target cells

  • Authors: Golnaz Atri Roozbahani, Miriam Kokal-Ribaudo, Mehdi Heidari Horestani, Thanakorn Pungsrinont, Aria Baniahmad
  • Journal: Cell Communication and Signaling
  • Year: 2024

The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer

  • Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer

  • Authors: Julia Kallenbach, Mahdi Rasa, Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Katrin Schindler, Aria Baniahmad
  • Journal: Journal of Experimental & Clinical Cancer Research
  • Year: 2024

The Novel Direct AR Target Gene Annexin A2 Mediates Androgen-Induced Cellular Senescence in Prostate Cancer Cells

  • Authors: Kimia Mirzakhani, Mehdi Heidari Horestani, Julia Kallenbach, Golnaz Atri Roozbahani, Aria Baniahmad
  • Journal: Biochemical Genetics
  • Year: 2024

Mr. Miguel Garcia-de la Virgen | Oncology | Best Researcher Award

Mr. Miguel Garcia-de la Virgen | Oncology | Best Researcher Award

Miguel Garcia-de la Virgen at IVC Evidensia – AĆŗna Especialidades Veterinariass, Spain

Profiles

Orcid

Summary

Mr. Miguel Garcia de la Virgen is a skilled veterinary oncologist with extensive experience in cancer treatment for animals. A resident of the European College of Veterinary Internal Medicine (ECVIM-CA), he is committed to advancing veterinary oncology through research and clinical practice.

Education

  • General Practitioner Certificate in Oncology (2014-2015) – European School of Veterinary Postgraduate Studies (ESVPS), Madrid
  • Master’s in Clinical Oncology (2013-2014) – Asociación EspaƱola de Veterinaria Aplicada (AEVA), Madrid
  • Veterinary Degree (2007-2012) – University of Zaragoza, Spain.

šŸ’¼Ā Professional Experience

  • Oncology Resident (2018-2020) – Hospital Veterinario AĆŗna Especialidades Veterinarias, Paterna, Valencia
  • Oncology Team Member (2016-2018) – Hospital Veterinari Montjuic, Barcelona
  • General Internship (2015-2016) – Hospital ClĆ­nic Veterinari, Universitat Autònoma de Barcelona
  • First Opinion Veterinary Clinician (2012-2015) – ClĆ­nica Veterinaria OrdĆ”s, AlgemesĆ­, ValĆØncia

šŸ”¬ Research Interests

  • Miguel focuses on innovative cancer treatments, clinical trials, and improving oncological care in veterinary medicine.

 

Publications

Impact of Toceranib Phosphate and Carprofen on Survival and Quality of Life in Dogs with Inflammatory Mammary Carcinomas

  • Authors: Miguel Garcia-de la Virgen, Isabel Del Portillo Miguel, Elisa Maiques, Ignacio PĆ©rez Roger, Enric Poch, Juan Borrego
  • Journal: Veterinary Sciences
  • Year: 2024

Clinical and genomic features of Listeria monocytogenes‐associated mesenteric lymphadenitis in a cat

  • Authors: Miguel Garcia-de la Virgen, Inmaculada López‐Almela, Alexandra Moura, Sergio VĆ”zquez, Sara Perez‐Montagud, Alexandre Leclercq, Marc Lecuit, Juan J Quereda
  • Journal: Journal of Veterinary Internal Medicine
  • Year: 2024